Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Altiratinib

Copy Product Info
😃Good
Catalog No. T2054Cas No. 1345847-93-9
Alias DCC-2701

Altiratinib (DCC-2701)(DCC-2701) is a novel c-MET/TIE-2/VEGFR inhibitor; effectively reduce tumor burden in vivo and block c-MET pTyr(1349)-mediated signaling, cell growth and migration as compared with an HGF antagonist in vitro.

Altiratinib

Altiratinib

Copy Product Info
😃Good
Purity: 99.75%
Catalog No. T2054Alias DCC-2701Cas No. 1345847-93-9
Altiratinib (DCC-2701)(DCC-2701) is a novel c-MET/TIE-2/VEGFR inhibitor; effectively reduce tumor burden in vivo and block c-MET pTyr(1349)-mediated signaling, cell growth and migration as compared with an HGF antagonist in vitro.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
5 mg$48In StockIn Stock
10 mg$79In StockIn Stock
25 mg$139In StockIn Stock
50 mg$226In StockIn Stock
100 mg$337-In Stock
1 mL x 10 mM (in DMSO)$54In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.75%
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Altiratinib AI Summary
Altiratinib exhibits potent inhibition of various receptor tyrosine kinases, including VEGFR, TrkC, TrkB, TrkA, TIE-2, and MET, with IC50 values ranging from 0.69 nM to 9.2 nM. Additionally, it has demonstrated significant antiproliferative activity against human KM12, SK-N-SH, and K562 cells with IC50 values of 1.4 nM, 1.2 nM, and 0.69 nM, respectively. The compound also shows inhibitory activity against c-MET and HDAC6 enzymes, as well as exhibiting cytotoxic effects against human HepG2 cells with an IC50 of 200.0 nM. Furthermore, Altiratinib has shown antiviral activity against SARS-CoV-2, including inhibition of SARS-CoV-2 induced cytotoxicity in both Caco-2 and VERO-6 cells and moderate inhibition of SARS-CoV-2 3CL-Pro protease. These bioactivities suggest that Altiratinib may have potential therapeutic applications in targeting pathways related to cancer progression, angiogenesis, cellular proliferation, and viral infections..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Altiratinib (DCC-2701)(DCC-2701) is a novel c-MET/TIE-2/VEGFR inhibitor; effectively reduce tumor burden in vivo and block c-MET pTyr(1349)-mediated signaling, cell growth and migration as compared with an HGF antagonist in vitro.
Targets&IC50
TrkA:0.85 nM, MET (Y1230C):0.37 nM, MET (Y1230C):1.2 nM, TrkC:0.85 nM, MET (D1228N):1.3 nM, Trk3:0.93 nM, VEGFR2:9.2 nM, FLT3:9.3 nM, Trk2:4.6 nM, Tie2:8 nM
SynonymsDCC-2701
Chemical Properties
Molecular Weight510.46
FormulaC26H21F3N4O4
Cas No.1345847-93-9
SmilesFc1ccc(NC(=O)C2(CC2)C(=O)Nc2cc(F)c(Oc3ccnc(NC(=O)C4CC4)c3)cc2F)cc1
Relative Density.1.557 g/cm3 (Predicted)
Storage & Solubility Information
StorageIn solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 240 mg/mL (470.16 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (3.92 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.9590 mL9.7951 mL19.5902 mL97.9509 mL
5 mM0.3918 mL1.9590 mL3.9180 mL19.5902 mL
10 mM0.1959 mL0.9795 mL1.9590 mL9.7951 mL
20 mM0.0980 mL0.4898 mL0.9795 mL4.8975 mL
50 mM0.0392 mL0.1959 mL0.3918 mL1.9590 mL
100 mM0.0196 mL0.0980 mL0.1959 mL0.9795 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Altiratinib | purchase Altiratinib | Altiratinib cost | order Altiratinib | Altiratinib chemical structure | Altiratinib formula | Altiratinib molecular weight